263 related articles for article (PubMed ID: 33317840)
1. Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies.
Muzaffar S; Shahid W; Riaz N; Saleem M; Ashraf M; Aziz-Ur-Rehman ; Bashir B; Kaleem A; Al-Rashida M; Baral B; Bhattarai K; Gross H
Bioorg Chem; 2021 Feb; 107():104525. PubMed ID: 33317840
[TBL] [Abstract][Full Text] [Related]
2. Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies.
Shahid W; Ashraf M; Saleem M; Bashir B; Muzaffar S; Ali M; Kaleem A; Aziz-Ur-Rehman ; Amjad H; Bhattarai K; Riaz N
Bioorg Chem; 2021 Oct; 115():105261. PubMed ID: 34416506
[TBL] [Abstract][Full Text] [Related]
3. Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: Design, synthesis, DFT calculations and molecular docking studies.
Nawaz Z; Riaz N; Saleem M; Iqbal A; Abida Ejaz S; Bashir B; Muzaffar S; Ashraf M; Aziz-Ur-Rehman ; Sajjad Bilal M; Krishna Prabhala B; Sajid S
Bioorg Chem; 2024 Feb; 143():106984. PubMed ID: 38056389
[TBL] [Abstract][Full Text] [Related]
4. Investigations of
Bashir B; Riaz N; Ejaz SA; Saleem M; Iqbal A; Ashraf M; Ejaz S; -Rehman AU; Aziz M; Bhattarai K
J Biomol Struct Dyn; 2023; 41(24):15549-15568. PubMed ID: 36946200
[TBL] [Abstract][Full Text] [Related]
5. Identification of phenylcarbamoylazinane-1,3,4-oxadiazole amides as lipoxygenase inhibitors with expression analysis and in silico studies.
Bashir B; Shahid W; Ashraf M; Saleem M; Aziz-Ur-Rehman ; Muzaffar S; Imran M; Amjad H; Bhattarai K; Riaz N
Bioorg Chem; 2021 Oct; 115():105243. PubMed ID: 34403937
[TBL] [Abstract][Full Text] [Related]
6. Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies.
Bashir B; Riaz N; Abida Ejaz S; Saleem M; Ashraf M; Iqbal A; Muzaffar S; Ejaz S; Aziz-Ur-Rehman ; Mohammad Kashif Mahmood H; Bhattarai K
Bioorg Chem; 2022 Dec; 129():106144. PubMed ID: 36116325
[TBL] [Abstract][Full Text] [Related]
7. Targeting new N-furfurylated 4-chlorophenyl-1,2,4-triazolepropionamide hybrids as potential 15-lipoxygenase inhibitors supported with
Yasin M; Shahid W; Ashraf M; Saleem M; Muzaffar S; Ejaz SA; Mahmood HMK; Bhattarai K; Riaz N
J Biomol Struct Dyn; 2023 Jul; 41(11):5166-5182. PubMed ID: 35699270
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
ElBordiny HS; El-Miligy MM; Kassab SE; Daabees H; Mohamed Ali WA; Abdelhamid Mohamed El-Hawash S
Eur J Med Chem; 2018 Feb; 145():594-605. PubMed ID: 29339254
[TBL] [Abstract][Full Text] [Related]
9. 4-Chlorophenyl-
Yasin M; Shahid W; Ashraf M; Saleem M; Muzaffar S; Aziz-Ur-Rehman ; Ejaz SA; Saeed A; Majer T; Bhattarai K; Riaz N
ACS Omega; 2022 Jun; 7(23):19721-19734. PubMed ID: 35721976
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors.
Chini MG; De Simone R; Bruno I; Riccio R; Dehm F; Weinigel C; Barz D; Werz O; Bifulco G
Eur J Med Chem; 2012 Aug; 54():311-23. PubMed ID: 22683242
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors.
Iranshahi M; Jabbari A; Orafaie A; Mehri R; Zeraatkar S; Ahmadi T; Alimardani M; Sadeghian H
Eur J Med Chem; 2012 Nov; 57():134-42. PubMed ID: 23047230
[TBL] [Abstract][Full Text] [Related]
12. 1,2,3-Triazole Tagged 3H-Pyrano[2,3-d]pyrimidine-6-carboxylate Derivatives: Synthesis, in Vitro Cytotoxicity, Molecular Docking and DNA Interaction Studies.
Boda SK; Pishka V; Lakshmi PVA; Chinde S; Grover P
Chem Biodivers; 2018 Jun; 15(6):e18000101. PubMed ID: 29660245
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of a new series of 3,5-bis((5-bromo-6-methyl-2-t-aminopyrimidin-4-yl)thio)-4H-1,2,4-triazol-4-amines and their cyclized products 'pyrimidinylthio pyrimidotriazolothiadiazines' as 15- lipo-oxygenase inhibitors.
Asghari T; Bakavoli M; Rahimizadeh M; Eshghi H; Saberi S; Karimian A; Hadizadeh F; Ghandadi M
Chem Biol Drug Des; 2015 Feb; 85(2):216-24. PubMed ID: 24925519
[TBL] [Abstract][Full Text] [Related]
14. Exploring ibuprofen derivatives as α-glucosidase and lipoxygenase inhibitors: Cytotoxicity and in silico studies.
Daud S; Abid OU; Sardar A; Abdullah S; Shahid W; Ashraf M; Ejaz SA; Saeed A; Shah BA; Niaz B
Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200013. PubMed ID: 35532320
[TBL] [Abstract][Full Text] [Related]
15. Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase.
Dianat S; Moghimi S; Mahdavi M; Nadri H; Moradi A; Firoozpour L; Emami S; Mouradzadegun A; Shafiee A; Foroumadi A
J Enzyme Inhib Med Chem; 2016; 31(sup3):205-209. PubMed ID: 27424740
[TBL] [Abstract][Full Text] [Related]
16. Substituted furans as potent lipoxygenase inhibitors: Synthesis, in vitro and molecular docking studies.
Vinayagam J; Gajbhiye RL; Mandal L; Arumugam M; Achari A; Jaisankar P
Bioorg Chem; 2017 Apr; 71():97-101. PubMed ID: 28143657
[TBL] [Abstract][Full Text] [Related]
17. Arylazolylthioacetanilide. Part 11: design, synthesis and biological evaluation of 1,2,4-triazole thioacetanilide derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Li Z; Cao Y; Zhan P; Pannecouque C; Balzarini J; Clercq ED; Shen Y; Liu X
Med Chem; 2013 Nov; 9(7):968-73. PubMed ID: 23072552
[TBL] [Abstract][Full Text] [Related]
18. Identification of NSAIDs as lipoxygenase inhibitors through highly sensitive chemiluminescence method, expression analysis in mononuclear cells and computational studies.
Shahid W; Ejaz SA; Al-Rashida M; Saleem M; Ahmed M; Rahman J; Riaz N; Ashraf M
Bioorg Chem; 2021 May; 110():104818. PubMed ID: 33784531
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer.
Saeed A; Ejaz SA; Sarfraz M; Tamam N; Siddique F; Riaz N; Qais FA; Chtita S; Iqbal J
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807227
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR studies of 3-allyl-4-prenyloxyaniline amides as potent 15-lipoxygenase inhibitors.
Jabbari A; Davoodnejad M; Alimardani M; Assadieskandar A; Sadeghian A; Safdari H; Movaffagh J; Sadeghian H
Bioorg Med Chem; 2012 Sep; 20(18):5518-26. PubMed ID: 22917856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
